PFE Financial Facts
Provision for taxes on income: 284MDiscontinued operations--net of tax (in dollars per share): 0
See Full Income Statement
Total shareholders' equity: 63.6B
Cash and cash equivalents: 2.09B
See Full Balance Sheet
Pfizer Inc. (PFE) Earnings
|
Expand Research on PFE
| Next EPS Date | 8/5/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +29.4% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/5/26  |
Q126 | N/A | $0.73 | N/A | N/A | $13.89B | = | N/A | N/A | ||
| 2/3/26 | Q425 | $0.66 | $0.58 | +$0.08 | $17.58B | $16.91B | = |  | | Details | |
| 11/4/25 | Q325 | $0.87 | $0.66 | +$0.21 | $16.7B | $16.8B | = | | | Details | |
| 8/5/25 | Q225 | $0.78 | $0.57 | +$0.21 | $14.7B | $13.47B | = | | | Details | |
| 4/29/25 | Q125 | $0.92 | $0.68 | +$0.24 | $13.72B | $14.09B | = | | | Details | |
| 2/4/25 | Q424 | $0.63 | $0.48 | +$0.15 | $17.8B | $17.28B | = | | | Details | |
| 10/29/24 | Q324 | $1.06 | $0.62 | +$0.44 | $17.7B | $14.92B | = | | | Details | |
| 7/30/24 | Q224 | $0.60 | $0.46 | +$0.14 | $13.3B | $13.03B | = | | | Details |
